These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2702054)

  • 21. Systemic scleroderma (progressive systemic sclerosis), chemical diabetes mellitus, psoriasis.
    Sauter LS
    Arch Dermatol; 1971 Jun; 103(6):682-5. PubMed ID: 5555861
    [No Abstract]   [Full Text] [Related]  

  • 22. [Systemic scleroderma in children].
    Plantin P; Gavanou J; Le Fur JM; Guillet G
    Arch Fr Pediatr; 1988 Dec; 45(10):805-8. PubMed ID: 3266459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Care of patients with scleroderma in the intensive care setting.
    Farber HW; Simms RW; Lafyatis R
    J Intensive Care Med; 2010 Sep; 25(5):247-58. PubMed ID: 20542965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [M scleroderma (with systemic progressive sclerosis) associated with clinical and biological signs of dermatomyositis and lupus erythematosus].
    Grupper C; Durepaire RM; Eisenmann D; Briche R
    Bull Soc Fr Dermatol Syphiligr; 1972; 79(3):219-20. PubMed ID: 4642837
    [No Abstract]   [Full Text] [Related]  

  • 25. The spectrum of scleroderma (II).
    LeRoy EC; Lomeo R
    Hosp Pract (Off Ed); 1989 Nov; 24(11):65-8, 69-72, 75-6 passim. PubMed ID: 2509504
    [No Abstract]   [Full Text] [Related]  

  • 26. Vascular disease in systemic sclerosis.
    Poredos P
    Vasa; 2011 Jan; 40(1):3-4. PubMed ID: 21375075
    [No Abstract]   [Full Text] [Related]  

  • 27. Systemic connective tissue diseases in India, VI. Raynaud's disease and pre-progressive systemic sclerosis (Pre-PSS).
    Malaviya AN; Narayanan K; Tiwari SC; Khan KM; Raina V; Pande JN
    J Assoc Physicians India; 1983 Oct; 31(10):625-8. PubMed ID: 6671930
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case of systemic sclerosis in childhood complicated by severe digital ulcers].
    Falcini F; Volpi M; Pierattelli M; Taccetti G; Pratesi G; Matucci Cerinich M
    Pediatr Med Chir; 1984; 6(5):703-7. PubMed ID: 6535137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible adverse effect of phenoxybenzamine therapy in a patient with progressive systemic sclerosis.
    Parker LP; Hahn BH; Osterland CK
    Arthritis Rheum; 1972; 15(5):535-9. PubMed ID: 4634806
    [No Abstract]   [Full Text] [Related]  

  • 30. Progressive systemic sclerosis (scleroderma).
    JAMA; 1973 Apr; 224(5 Suppl):711-6. PubMed ID: 4739736
    [No Abstract]   [Full Text] [Related]  

  • 31. Review: evidence that systemic sclerosis is a vascular disease.
    Matucci-Cerinic M; Kahaleh B; Wigley FM
    Arthritis Rheum; 2013 Aug; 65(8):1953-62. PubMed ID: 23666787
    [No Abstract]   [Full Text] [Related]  

  • 32. Nutrition in systemic sclerosis.
    Recasens MA; Puig C; Ortiz-Santamaria V
    Reumatol Clin; 2012; 8(3):135-40. PubMed ID: 22197834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis.
    Nishibu A; Sakai E; Oyama N; Yamamoto T
    Australas J Dermatol; 2012 May; 53(2):e32-3. PubMed ID: 22571581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Raynaud phenomenon in systemic sclerosis.
    Sinnathurai P; Schrieber L
    Intern Med J; 2013 May; 43(5):476-83. PubMed ID: 23347192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked digital skin temperature increase mediated by thermal biofeedback in advanced scleroderma.
    Wilson E; Belar CD; Panush RS; Ettinger MP
    J Rheumatol; 1983 Feb; 10(1):167-8. PubMed ID: 6842480
    [No Abstract]   [Full Text] [Related]  

  • 36. Gastrointestinal and Hepatic Disease in Systemic Sclerosis.
    Frech TM; Mar D
    Rheum Dis Clin North Am; 2018 Feb; 44(1):15-28. PubMed ID: 29149923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Iloprost for the treatment of systemic sclerosis].
    Hachulla E; Launay D; Hatron PY
    Presse Med; 2008 May; 37(5 Pt 2):831-9. PubMed ID: 18035518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Raynaud syndrome].
    Knorr M; Schmid A; steurer J; Vetter W
    Schweiz Rundsch Med Prax; 1986 Jul; 75(29):893-6. PubMed ID: 3738337
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathogenesis of systemic sclerosis: a vascular hypothesis.
    Campbell PM; LeRoy EC
    Semin Arthritis Rheum; 1975 May; 4(4):351-68. PubMed ID: 1135634
    [No Abstract]   [Full Text] [Related]  

  • 40. Raynaud's phenomenon affecting the tongue of a patient with scleroderma.
    Bridges MJ; Kelly CA
    Ann Rheum Dis; 2002 May; 61(5):472. PubMed ID: 11959778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.